Chikungunya Outbreak in Seychelles
The Centers for Disease Control and Prevention (CDC) has issued a Level 2 Travel Health Notice for Seychelles due to an active chikungunya outbreak. This alert recommishes travelers to take precautions against mosquito-borne illness transmission.
About Chikungunya
Chikungunya is a viral infection transmitted primarily by Aedes mosquitoes (the same vectors for dengue and Zika). The virus causes symptoms including fever, joint pain, headache, muscle pain, and rash that typically appear 3–7 days after infection. While most individuals recover completely, joint pain can persist for weeks or months in some cases.
Risk Assessment
The outbreak classification reflects sustained transmission in the region. Travelers to Seychelles face moderate risk, particularly in areas with high mosquito populations. The risk increases during rainy seasons when mosquito breeding habitats proliferate.
Prevention Recommendations
Mosquito Bite Prevention:
- Use EPA-registered insect repellents (DEET, picaridin, oil of lemon eucalyptus)
- Wear lightweight, loose-fitting clothing that covers arms and legs
- Remain in air-conditioned or screened accommodations
- Avoid outdoor activities during dawn and dusk when mosquitoes are most active
- Consider permethrin-treated clothing and gear
Before Travel:
- Consult travel health resources for current conditions
- Review your personal health status and medication interactions with repellents
- Pack sufficient supplies of preferred insect repellent
Post-Travel Monitoring
If symptoms develop within two weeks of return, seek medical evaluation and inform healthcare providers of travel history to Seychelles.
Pharmacist's Note: Insect repellents containing DEET (20–30%) or picaridin (20%) are evidence-based for mosquito prevention and are generally safe when applied per label instructions. Pregnant individuals and young children should use lower DEET concentrations (10–15%) or picaridin as alternatives. No specific antiviral medications exist for chikungunya; treatment is supportive. Over-the-counter NSAIDs or acetaminophen may help manage symptoms, but always verify compatibility with personal medications. Travelers should confirm repellent formulations don't interact with sunscreen or medications before departure.
References
- CDC Travel Health Notices: https://wwwnc.cdc.gov/travel/notices
- CDC Chikungunya Information: https://www.cdc.gov/chikungunya